Post-fall Syndrome
Conditions
Brief summary
The main objective of this study is to evaluate the feasibility and acceptability of the use of the robot SAFEWALKER complement classical rehabilitation in a group of elderly patients over 70 years during the rehabilitation of post-fall syndrome.
Detailed description
The post-fall syndrome is an acute functional complications of falls that affects nearly one in five elderly fallers. It combines phobia of the previous vacuum, axial and hypertension astasia abasia. Unrecognized and untreated, it progresses to a major regressive syndrome, severe physical, psychological and social implications. Only an early rehabilitation for an early resumption of walking, prevents such a development. The main element is to support and encourage the subject to walking. In practice, it was found that the physiotherapist can not be present daily and the duration of its intervention is often short-lived. This study will examine the contribution of a medical device of a walking aid (SAFEWALKER the robot) in the rehabilitation and empowerment of seniors with a post-fall syndrome. The SAFEWALKER, which is a walking aid device (http://www.safewalker.com), completes the support action exercised by a third person, by reducing support and securing travel. It allows the subject to move alone at will and is a continuity in relation to the management of the physiotherapist, a potential source of motivation. The hypothesis is that the SAFEWALKER device can be complementary to the walking rehabilitation in post-fall syndrome.
Interventions
DEVICESAFEWALKER
Medical device walking aids.
Sponsors
Safe Step and Walk Movement (SSWM), Toulouse, France
University Hospital, Toulouse
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients hospitalized for the treatment of post-fall syndrome
Exclusion criteria
* Demential pathology (Mini Mental State \<20) * Parkinson's disease and other degenerative neurological disorders * Stroke sequelae * Fractures members in the previous 12 months * Lower limb prostheses in place within 6 months prior * Psychiatric disease * Presence of mucocutaneous lesions perineal * Obesity (weight \>120 kg)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Feasibility of Safewalker | Day 14 | Number of steps performed at each of the rehabilitation sessions A composite measure based on questionnaires assessing the feasibility (patient and therapist). |
| Acceptability of Safewalker | Day 14 | A composite measure based on questionnaires assessing the acceptability (patient and therapist). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Step length | Day 14 | This parameter will be collected by a pedometer (manual and electronic) and embedded soles (Dynafoot ®) and motion sensors (Bioval ®). |
| Number of falls during the study | Day 14 | The nurse will report the number of times that the patient fell during his hospitalization |
| Walking speed | Day 14 | This parameter will be collected by a pedometer (manual and electronic) and embedded soles (Dynafoot ®) and motion sensors (Bioval ®). |
| Independence in basic activities of daily living | Day 14 | Using the Activities of Daily Living scale |
| The fear of falling | Day 14 | Using the Falls Efficacy Scale International |
| Quality of life | Day 14 | Using the Short Form 36 scale |
| Retropulsion degree | Day 14 | This parameter will be collected by a pedometer (manual and electronic) and embedded soles (Dynafoot ®) and motion sensors (Bioval ®). |
Countries
France
Outcome results
None listed